Antithrombotic treatment in patients undergoing transcatheter aortic valve replacement

Keyphrases

• Antithrombotic Therapy 100%
• Transcatheter Aortic Valve Replacement 100%
• Patients with Coronary Artery Disease 20%
• Atrial Fibrillation 20%
• Anticoagulant Therapy 20%
• Antiplatelet Therapy 20%
• Heparin 20%
• Aspirin 20%
• Percutaneous Coronary Intervention 20%
• Clinical High Risk 20%
• Thrombus Formation 20%
• Standard of Care 20%
• Guideline-based 20%
• Underlying Risk Factors 20%
• Conjugation 20%
• Surgical Valve Replacement 20%
• Surgical Aortic Valve Replacement 20%
• Dual Antiplatelet Therapy 20%
• Pharmacological Therapy 20%
• Clopidogrel 20%
• Post-percutaneous Coronary Intervention 20%
• Bioprosthetic 20%

Medicine and Dentistry

• Antithrombotic 100%
• Percutaneous Aortic Valve Replacement 100%
• Antiplatelet 40%
• Percutaneous Coronary Intervention 40%
• Coronary Artery Disease 20%
• Drug Therapy 20%
• Anticoagulant Therapy 20%
• Atrial Fibrillation 20%
• Observational Study 20%
• Heparin 20%
• Acetylsalicylic Acid 20%
• Stenting 20%
• Valve Replacement 20%
• Clopidogrel 20%
• Blood Clotting 20%
• Aortic Valve Replacement 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticoagulant Agent 100%
• Antiplatelet 66%
• Pharmacotherapy 33%
• Coronary Artery Disease 33%
• Observational Study 33%
• Atrial Fibrillation 33%
• Acetylsalicylic Acid 33%
• Heparin 33%
• Thrombus 33%
• Clopidogrel 33%